KRBP
Closed
Kiromic Biopharma inc
0.0403
0.0000 (0.00%)
Last Update: 13 Jun 2025 16:30:00
Yesterday: 0.0403
Day's Range: 0.0403 - 0.0403
Send
sign up or login to leave a comment!
When Written:
2.86
Kiromic Biopharma Inc is a clinical-stage biotechnology company that focuses on developing immuno-oncology therapeutics and targeted therapies for cancer. The company's proprietary technology platform enables the discovery and development of novel biomarkers, therapeutic targets, and drugs for the treatment of cancer. Kiromic Biopharma's lead product candidate, KM-074, is a targeted therapy for ovarian cancer that is currently in Phase I clinical trials. The company is also developing other product candidates for the treatment of various types of cancer, including breast cancer, pancreatic cancer, and liver cancer. Kiromic Biopharma is headquartered in Houston, Texas, and was founded in 2014.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








